Literature DB >> 8923446

Neuropathology of human sympathetic autonomic ganglia.

R E Schmidt1.   

Abstract

The neuropathologic alterations which underlie autonomic nervous system dysfunction in aging and in a variety of diseases have been systematically examined in the sympathetic ganglia of a series of 347 autopsied adults and in a review of previously published studies. Markedly swollen terminal axons containing neurofilamentous aggregates were found immediately adjacent to the neuronal cell bodies of prevertebral sympathetic ganglia in aging, in diabetes, and, to a lesser extent, in alcoholism. Dystrophic axons appeared to involve subpopulations of intraganglionic nerve fibers, chiefly those containing neuropeptide Y (NPY), and were more frequent in males than females. Neither aging nor diabetes resulted in significant numbers of actively degenerating neurons or a substantial decrease in neuronal density. Parenchymal aggregates of lymphocytes in the ganglionic neuropil and perivascular regions represented a frequent histologic finding in both prevertebral and paravertebral ganglia; however, they were not selectively increased in frequency or intensity in diabetic subjects or in any other disease entity. Many dilated clear "vacuoles," apparently located within the neuronal cell bodies of paravertebral and prevertebral ganglia according to light microscopy, were subsequently shown by electron microscopy to represent vacuolated or fluid-filled neurites, most likely terminal axons or synapses. Vacuolated neurites were more frequent in, although not confined to, diabetic patients. Similar pathologic findings have been reported in studies of sympathetic ganglia in various human diseases. The frequency of some pathologic lesions in control populations as a function of age or gender necessitates the careful selection of a relatively large, appropriately matched, control population for comparison with presumed disease-induced ganglionic neuropathology, and emphasizes the importance of quantitative comparisons.

Entities:  

Mesh:

Year:  1996        PMID: 8923446     DOI: 10.1002/(SICI)1097-0029(19961001)35:2<107::AID-JEMT2>3.0.CO;2-N

Source DB:  PubMed          Journal:  Microsc Res Tech        ISSN: 1059-910X            Impact factor:   2.769


  6 in total

1.  Morphological changes in peri-prostatic sympathetic ganglion cells in aging males.

Authors:  Lea Rath-Wolfson; Asaf Shvero; Golan Bubis; Galina Buzaverov; Aliza Zeidman; Edward Ram; Rumelia Koren
Journal:  Mol Clin Oncol       Date:  2017-03-16

2.  Insulin-like growth factor I reverses experimental diabetic autonomic neuropathy.

Authors:  R E Schmidt; D A Dorsey; L N Beaudet; S B Plurad; C A Parvin; M S Miller
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

Review 3.  Reactive oxygen species inactivate neuronal nicotinic acetylcholine receptors through a highly conserved cysteine near the intracellular mouth of the channel: implications for diseases that involve oxidative stress.

Authors:  Arjun Krishnaswamy; Ellis Cooper
Journal:  J Physiol       Date:  2011-10-03       Impact factor: 5.182

4.  Non-obese diabetic mice rapidly develop dramatic sympathetic neuritic dystrophy: a new experimental model of diabetic autonomic neuropathy.

Authors:  Robert E Schmidt; Denise A Dorsey; Lucie N Beaudet; Kathy E Frederick; Curtis A Parvin; Santiago B Plurad; Matteo G Levisetti
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

5.  Neuritic dystrophy and neuronopathy in Akita (Ins2(Akita)) diabetic mouse sympathetic ganglia.

Authors:  Robert E Schmidt; Karen G Green; Lisa L Snipes; Dongyan Feng
Journal:  Exp Neurol       Date:  2008-12-10       Impact factor: 5.330

Review 6.  Pathological classification of equine recurrent laryngeal neuropathy.

Authors:  Alexandra C E Draper; Richard J Piercy
Journal:  J Vet Intern Med       Date:  2018-04-24       Impact factor: 3.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.